BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Shareholders’ equity 2018–2025
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) shareholders’ equity at each fiscal year-end, per SEC filings.
$112.2MFY2025 · since FY2018: -$15.5M → $112.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $112.2M | +34.7% |
| FY2024 | $83.3M | — |
| FY2020 | $307.8M | +752.6% |
| FY2019 | -$47.2M | -203.4% |
| FY2018 | -$15.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice